NCT06438978 - Tuberculosis Vaccine in Healthy Indian Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 19, 2024

Primary Completion Date

January 29, 2024

Study Completion Date

July 27, 2024

Conditions

Tuberculosis

Interventions

BIOLOGICAL

Tuberculosis Vaccine

"1. Live, attenuated Mycobacterium tuberculosis (M. tb)- MTBVAC (MTBVAC)01 strain~2. 3-17x105CFU (Per dose) Sucrose Sodium glutamate~3. Lyophilized pellet in vials (10doses)~4. 0.1 mL/dose (After reconstitution with 1 mL/vial sterilized water for injection)"

Trial Locations (1)

500082

NIMS, Hyderabad, Hyderabad

All Listed Sponsors

lead

Bharat Biotech International Limited

INDUSTRY